Conferences are important engines of the life science industry, and Big3Bio provides recaps for several of the events, from major partnering meetings to private forums, that occur in the “Big 3” regions. These recaps not only provide information on developments and what happened, but also insight on what’s to come.
Big3Bio events are covered by Big3Bio editor Marie Daghlian (pictured) and Dr. Karen Ring.
LATEST RECAPS
Urdea Talks About Why Diagnostics Companies Fail By Marie Daghlian The classroom at QB3 on the UCSF campus was small, only sixty seats, but it was packed—all the seats were taken and at least thirty more people lined the walls and sat in the center aisle. Before introducing Mickey Urdea, health sciences incubator QB3 Executive [...]
By Marie Daghlian The buzz around artificial intelligence, or AI, is palpable—similar to the buzz around CRISPR and immuno-oncology just a few years ago. VCs are throwing money at startups that are using AI. Proponents say it can solve the world’s problems, do what humans cannot. Others worry that it will run away from humans, [...]
By Marie Daghlian Editor, Big3Bio The life sciences industry is doing great. That was the considered opinion of life sciences industry experts that was also exemplified by the buoyant mood of many of the 30,000 or so people involved in its business who descended on San Francisco during the second week of January to attend [...]
Take Charge of Your Career but Leave Room for Serendipity By Marie Daghlian There’s no one way to rise to the top said the four women sitting on the stage at Women in Bio’s mid-March event held at JLABS in South San Francisco as part of Women’s History Month, which recognizes and celebrates women’s accomplishments. [...]
Shaping Patient-Centric Health Care By Marie Daghlian Rapid advances in genomics and technology are transforming personalized medicine into precision medicine. Genomic medicine is here, Euan Ashley said as he welcomed a gathering of more than 8,000 people to the Precision Medicine World Conference (PMWC) held in Silicon Valley. Ashley, director of Stanford University’s Clinical Genomics [...]
Developing Therapies for Rare Diseases: Patients Come First By Marie Daghlian Rare disease drug development is personal and often driven by patient advocacy. In a lively and engaging fireside chat titled “Unmet needs, uncommon commitment: shift toward investment in rare diseases,” Henri Termeer, an early advocate of rare disease drug development and a serial entrepreneur, [...]
Upbeat Mood but Uncertainty Ahead By Marie Daghlian The Hilton Hotel at Union Square in downtown San Francisco hummed with energy as more than 3,300 life sciences professionals converged for the ninth annual Biotech Showcase during the second week of January 2017. Held at the same time as the annual J.P. Morgan Healthcare Conference, neither [...]
Networking on Steroids: Early stage entrepreneurs speed date with investors at RESI in San Francisco By Marie Daghlian You have 30 minutes per meeting, enough time to make your pitch, find out if there is a potential connection, and move on to the next meeting. It’s networking on steroids and it works for many of [...]
By Marie Daghlian; Photos by Eugene Borodin A smart contact lens that monitors blood glucose, video games that promise to enhance cognition, a novel and simple biopsy device that improves patient comfort—these are just a few of the next generation of medical devices showcased at the third annual Rosenman Institute Symposium, held June 22nd at Byers [...]
By Dr. Karen Ring for CIRM/Big3Bio: CIRM kicked off the 2016 International Society for Stem Cell Research (ISSCR) Conference in San Francisco with a public stem cell event yesterday that brought scientists, patients, patient advocates and members of the general public together to discuss the many ways stem cells are being used in the clinic [...]